Incidence, morbidity and mortality of patients with achalasia in England: findings from a study of nationwide hospital and primary care data
- PMID: 29925629
- DOI: 10.1136/gutjnl-2018-316089
Incidence, morbidity and mortality of patients with achalasia in England: findings from a study of nationwide hospital and primary care data
Abstract
Background: Achalasia is an uncommon condition characterised by failed lower oesophageal sphincter relaxation. Data regarding its incidence, prevalence, disease associations and long-term outcomes are very limited.
Methods: Hospital Episode Statistics (HES) include demographic and diagnostic data for all English hospital attendances. The Health Improvement Network (THIN) includes the primary care records of 4.5 million UK subjects, representative of national demographics. Both were searched for incident cases between 2006 and 2016 and THIN for prevalent cases. Subjects with achalasia in THIN were compared with age, sex, deprivation tand smoking status matched controls for important comorbidities and mortality.
Results: There were 10 509 and 711 new achalasia diagnoses identified in HES and THIN, respectively. The mean incidence per 100 000 people in HES was 1.99 (95% CI 1.87 to 2.11) and 1.53 (1.42 to 1.64) per 100 000 person-years in THIN. The prevalence in THIN was 27.1 (25.4 to 28.9) per 100 000 population. Incidence rate ratios (IRRs) were significantly higher in subjects with achalasia (n=2369) compared with controls (n=3865) for: oesophageal cancer (IRR 5.22 (95% CI: 1.88 to 14.45), p<0.001), aspiration pneumonia (13.38 (1.66 to 107.79), p=0.015), lower respiratory tract infection (1.33 (1.05 to 1.70), p=0.02) and mortality (1.33 (1.17 to 1.51), p<0.001). The median time from achalasia diagnosis to oesophageal cancer diagnosis was 15.5 (IQR 20.4) years.
Conclusion: The incidence of achalasia is 1.99 per 100 000 population in secondary care data and 1.53 per 100 000 person-years in primary care data. Subjects with achalasia have an increased incidence of oesophageal cancer, aspiration pneumonia, lower respiratory tract infections and higher mortality. Clinicians treating patients with achalasia should be made aware of these associated morbidities and its increased mortality.
Keywords: achalasia; aspiration pneumonia; epidemiology; lower respiratory tract infection; mortality; oesophageal cancer.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Incidence, Morbidity, and Mortality of Achalasia: A Nationwide, Population-Based Cohort Study in South Korea.Gut Liver. 2023 Nov 15;17(6):894-904. doi: 10.5009/gnl220334. Epub 2023 Mar 29. Gut Liver. 2023. PMID: 36987382 Free PMC article.
-
Outcomes of pneumatic dilatation and Heller's myotomy for achalasia in England between 2005 and 2016.Gut. 2019 Jul;68(7):1146-1151. doi: 10.1136/gutjnl-2018-316544. Epub 2019 Jan 3. Gut. 2019. PMID: 30606814
-
A prospective study of the clinical features, manometric findings, incidence and prevalence of achalasia in Singapore.J Gastroenterol Hepatol. 1999 Aug;14(8):791-5. doi: 10.1046/j.1440-1746.1999.01950.x. J Gastroenterol Hepatol. 1999. PMID: 10482430
-
Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomes.World J Gastroenterol. 2013 Sep 21;19(35):5806-12. doi: 10.3748/wjg.v19.i35.5806. World J Gastroenterol. 2013. PMID: 24124325 Free PMC article. Review.
-
Achalasia: an overview of diagnosis and treatment.J Gastrointestin Liver Dis. 2007 Sep;16(3):297-303. J Gastrointestin Liver Dis. 2007. PMID: 17925926 Review.
Cited by
-
Incidence, Morbidity, and Mortality of Achalasia: A Nationwide, Population-Based Cohort Study in South Korea.Gut Liver. 2023 Nov 15;17(6):894-904. doi: 10.5009/gnl220334. Epub 2023 Mar 29. Gut Liver. 2023. PMID: 36987382 Free PMC article.
-
Risk of Esophageal Cancer in Achalasia: A Matched Cohort Study Using the Nationwide Veterans Affairs Achalasia Cohort.Am J Gastroenterol. 2024 Apr 1;119(4):635-645. doi: 10.14309/ajg.0000000000002591. Epub 2023 Nov 17. Am J Gastroenterol. 2024. PMID: 37975607 Free PMC article.
-
Achalasia as an Unusual Cause of Acute Cellular Rejection of a Transplanted Heart.Case Rep Cardiol. 2022 Sep 28;2022:2054727. doi: 10.1155/2022/2054727. eCollection 2022. Case Rep Cardiol. 2022. PMID: 36254142 Free PMC article.
-
Achalasia.Nat Rev Dis Primers. 2022 May 5;8(1):28. doi: 10.1038/s41572-022-00356-8. Nat Rev Dis Primers. 2022. PMID: 35513420 Review.
-
Achalasia-associated megaoesophagus presenting with dyspnoea and cough.BMJ Case Rep. 2024 Feb 17;17(2):e258950. doi: 10.1136/bcr-2023-258950. BMJ Case Rep. 2024. PMID: 38367990
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources